Lupin gained 1.85% to Rs 575 at 14:47 IST on BSE after posting 46.79% surge in net profit to Rs 443.38 core on 27.05% rise in total income to Rs 2741.11 crore in the year ended March 2008 over the year ended March 2007.
The stock hit a high of Rs 584.70 and a low of Rs 557 so far during the day. The stock had a 52-week high of Rs 745 on
The company’s current equity is Rs 82.08 crore. Face value per share is Rs 10.
The current price of Rs 575 discounts its Q3 December 2007 annualised EPS of Rs 83, by a PE multiple of 6.93.
However, Lupin’s net profit declined 44% to Rs 76.64 crore on 0.18% fall in total income to Rs 646.40 crore in Q4 March 2008 over Q4 March 2007.
In April 2008, Lupin’s subsidiary in Japan, Kyowa Pharmaceutical Industry Co, received approvals from the country's ministry of health and labour welfare for 10 products.
Lupin is engaged in manufacturing active pharmaceutical ingredients and formulations.
No comments:
Post a Comment